PUBLIC CONTRACT · 2022
4160076/2022 - Antitripsina alfa-1 1000 mg (50 mg/ml AMP 20ML) po sol inj (respreeza)
- Contract value
- €14,204.20
- Signed on
- 22 February 2022
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 9007015PUBLISHED SUBJECT
4160076/2022 - ANTITRIPSINA ALFA-1 1000 MG (50 MG/ML AMP 20ML) PO SOL INJ (RESPREEZA)
Parties involved
- Place of performance
- Portugal, Setúbal, Barreiro
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- CSL Behring, Lda · Tax ID 503047201
Values and timeline
- Contract price
- €14,204.20
- Procedure base price
- €14,204.20
- Total effective price
- €14,204.20
- Publication date
- 3 March 2022
- Award date
- 22 February 2022
- Signing date
- 22 February 2022
- Performance period
- 1 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 24.º, n.º 1, alínea e), subalínea ii) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 5800532
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.